一种简单高效的结合转移克隆方法*

为了建立一种将整合在染色体上的重组自杀质粒重新环化成环形质粒的技术方法 ,以体内表达技术筛选到的痢疾杆菌融合菌株为出发点 ,借助辅助质粒pMT999或pRK2 0 1 3进行了结合转移实验 ,成功地建立了一种结合转移克隆方法 ,并且具有较高的克隆效率。     

一种新的广谱寄主的DNA克隆技术—PRK290与PRK2013双载体系统介绍

近年来,一种用于DNA克隆的双载体系统发展十分迅速。这种系统有许多优点,特别是它广谱寄主的特性,是我们过去常用的一些载体系统所不具有的。在实际应用中,它已显示出作为一种有效的多用途的DNA克隆载体的潜力。这就是以PRK290质粒为克隆载体、以PRK2013质粒为帮助质粒(helper Plasmid)可转移进各种革兰氏阴性菌的双载系统。     

质粒拯救法克隆细菌基因组大片段

[目的]细菌基因组大片段尤其是基因簇的克隆与操作,是细菌基因功能分析的一个难点.基因组测序工作的不断完成和序列信息的大量积累,为细菌基因组:DNA的操作提供了方便.本文报道了利用细菌的全基因组信息和质粒拯救法的原理建立的一种克隆细菌基因组大片段的方法.[方法]首先,根据基因组序列信息,在待克隆片段的一侧扩增一段DNA,并将其克隆到自杀载体上构建打靶质粒,然后,将打靶质粒整合到细菌的基因组中构建重组菌,提取重组菌的基因组DNA,酶切,自连,转化,将自杀质粒与待克隆的目的片段一起拯救出来.最后,根据需要将拯救的DNA片段亚克隆到新的载体中.[结果]我们利用该方法克隆了布鲁氏菌中长度为11kb的virB操纵子,并构建了互补质粒.将该质粒导入到virB的突变株中后使virB操纵子的转录活性得到了恢复,表明该策略切实可行.[结论]这种重组克隆策略给我们提供了一种新的对细菌基因组大片段进行操作的方法.     

中国人促红细胞生成素cDNA的克隆及其在COS—7细胞中的表达

利用PCR技术,以中国人促红细胞生成素(EPO)次全基因组为模板,进行了基因修补和重组,克隆出EPO cDNA全序列。同时发现中国人EPO cDNA与国外的克隆比较有一个核苷酸的差异,导致第62位氨基酸是丝氨酸,不是亮氨酸。将人EPO cDNA基因插入表达载体pSV2-dhfr中的不同克隆位点,构建了6种不同的转移载体质粒,即pSV2-dhfr/F1,pSV2/N2,pSV2-dhfr/F3,pSV2-dhfr/P4,pSV2-dhfr/G1和pSV2-dhfr/G3。将它们分别转染导入COS-7细胞,结果表明6种转移载体质粒转染的细胞上清液都有明显的EPO活性。人EPO cDNA基因转移载体质粒在COS-7细胞中的表达水平高于人次全EPO基因组转移载体质粒。     

中国人促红细胞生成素cDNA的克隆及其在COS-7细胞中的表达

利用PCR技术。以中国人促红细胞生成素(EPO)次全基因组为模板,进行了基因修补和重组．克隆出EPO cDNA全序列。同时发现中国人EPO cDNA与国外的克隆比较有一个核苷酸的差异,导致第62位氨基酸是丝氨酸．不是亮氨酸。将人EPO cDNA基因插入表达载体pSV2-dhfr中的不同克隆位点,构建了6种不同的转移载体质粒,即psV2 dhfr／F1,pSV2／F2,pSV2 dbfT／F3,pSV2 dhfr／F4,pSV2-dhfr／G1和psV2 dhfr／G3。将它们分别转染导人COS-7细胞,结果表明6种转移载体质粒转染的细胞上清液都有明显的EPO活性。人EPO cDNA基因转移载体质粒在COS-7细胞中的表达水平高于人次全EPO基因组转移载体质粒。     

无限制克隆技术研究进展及其应用

无限制克隆(restriction-free cloning,RFC)是近年来建立起来的一种简单通用的DNA克隆技术,它可以精确地将目的片段插入到质粒内任意位置,是一种不受酶切位点、连接酶效率、目的基因长度或载体序列等条件限制的新型DNA重组技术.与其他多种克隆方法相比,RFC技术拥有不可替代的优势.本文在总结国内外RFC技术研究的基础上,系统阐述了RFC技术的原理、特点和在克隆方面的研究进展,并探讨其在分子生物学和合成生物学等领域的应用价值.     

大肠杆菌-鸭疫里默氏杆菌高效穿梭质粒pFY02的构建和应用

鸭疫里默氏杆菌(Riemerella anatipestifer,RA)是引起鸭、鹅、火鸡等家禽传染性败血症及浆膜炎的主要病原。目前主要通过基因缺失及基因回补的方法对鸭疫里默氏杆菌的基因功能进行研究。然而,目前使用的穿梭质粒pLMF03存在结合转移效率低、酶切位点少等缺陷,不能用于所有鸭疫里默氏杆菌基因的回补。为解决这一问题,文中将结合转移位点oriT、鸭疫里默氏杆菌复制起始基因pRA0726ori、高表达启动子基因及多种酶切位点逐一克隆至质粒pPM5,构建了新的穿梭质粒pFY02。结果表明,该质粒能够稳定存在于鸭疫里默氏杆菌,且具有较高的结合转移效率。通过回补鸭疫里默氏杆菌tonB2基因缺失株表明,该质粒可用于鸭疫里默氏杆菌基因的回补。总之,文中构建的穿梭质粒pFY02更加完善了用于鸭疫里默氏杆菌基因回补的材料。     

2001年的分子生物学

在过去的十年里,分子生物学家在克服遗传转移障碍这一领域已取得一系列成就:不仅开发了cosmid克隆、植物的Ti质粒转染以及cDNA克隆等技术,而且扩展了电激法的适用     

人乳头瘤病毒16型和11型L1基因双价重组杆状病毒转移质粒的构建及鉴定

目的：构建人乳头瘤病毒16型与11型L1基因双价重组杆状病毒转移质粒并对其进行鉴定。方法：采用：PCR法从尖锐湿疣组织标本中扩增人乳头瘤病毒11型晚期基因L1,并对其进行克隆测序;利用基因重组技术将人乳头瘤病毒16型和11型L1晚期基因共同装入杆状病毒转移载体中,分别位于强启动子Ppolh和弱启动子P10之下;利用酶切和PCR技术对双价重组杆状病毒转移质粒进行鉴定。结果：PCR扩增法获得尖税湿疣组织中感染的人乳头瘤病毒11型的L1基因,得到人乳头瘤病毒16型L1和11型L1基因双价重组杆状病毒转移质粒,经酶切电泳鉴定验证重组成功。结论：本研究成功构建了双价重组杆状病毒转移质粒,为进一步构建双价L1蛋白表达系统进而建立双价基因工程亚单位疫苗打下基础。     

大肠杆菌BL21(DE3)中定向进化突变体库构建的方法比较

定向进化的突变体库建立是定向进化是否成功的关键因素,只有建立足够大的库容才有可能筛选到合适的突变体。然而用来做定向进化的宿主菌的转化效率并不总是那么高,难以达到建库要求。而且在以常规分子克隆方法做连接转化时,耗时长,效率低等问题也影响了突变体库的建立,高效的克隆转化方法是定向进化所需求的。本文以大肠杆菌BL21(DE3)为转化宿主菌,挑选了一种新的高效的克隆转化方法,与现在实验室常规克隆转化方法进行了比较,证明了PCR多聚质粒的克隆转化方法在定向进化突变体库构建中的优势。为定向进化突变体库的构建提供了新的高效可靠的技术方法。     

Optimized protocols and plasmids for in vivo cloning in yeast

Saccharomyces cerevisiae has proven a valuable system for the construction of plasmids via gap repair or in vivo cloning. The method allows cloning with superior accuracy and without the need to use restriction enzymes. However, despite its remarkable efficiency, the process may occasionally require the screening of large number of candidates. We have previously reported that by simply using shuttle plasmids that allow blue/white selection in Escherichia coli, it is possible to pre-select for positive clones. Here, we demonstrate that the same strategy can be used to assemble plasmids from several ectopic DNA fragments, which are all introduced in yeast cells by a simple transformation step. Further, to facilitate the subcloning of the fragment cloned into other targeting or expression vectors, the multi-cloning sites of three shuttle plasmids have been extended to include fifteen new restriction enzyme recognition sites.     

Integration of PCR fragments at any specific site within cloning vectors without the use of restriction enzymes and DNA ligase

Here, we describe a method that offers a unique way to engineer plasmids with precision but without digestion using restriction enzymes for the insertion of DNA. The method allows the insertion of PCR fragments in between any two nucleotides within a target plasmid. The only requirement is that the amplified fragments must be embedded between DNA sequences homologous to the site in which the integration is planned. This method is an adaptation of the QuikChange Site-Directed Mutagenesis protocol. It is simpler than the existing cloning strategies and is suitable for multiparallel constructions of new plasmids. We have demonstrated its utility by constructing plasmids in which we have successfully integrated PCR fragments up to 1117 bp.     

Improved broad-host-range plasmids for DNA cloning in gram-negative bacteria

Improved broad-host-range plasmid vectors were constructed based on existing plasmids RSF1010 and RK404. The new plasmids pDSK509, pDSK519, and pRK415, have several additional cloning sites and improved antibiotic-resistance genes which facilitate subcloning and mobilization into various Gram-negative bacteria. Several new polylinker sites were added to the Escherichia coli plasmids pUC118 and pUC119, resulting in the new plasmids, pUC128 and pUC129. These plasmids facilitate the transfer of cloned DNA fragments to the broad-host-range vectors. Finally, the broad-host-range cosmid cloning vector pLAFR3 was improved by the addition of a double cos casette to generate the new plasmid, pLAFR5. This latter cosmid simplifies vector preparation and has permitted the rapid cloning of genomic DNA fragments generated with Sau3A. The resulting clones may be introduced into other Gram-negative bacteria by conjugation.     

High-throughput cloning and expression in recalcitrant bacteria

We developed a generic method for high-throughput cloning in bacteria that are less amenable to conventional DNA manipulations. The method involves ligation-independent cloning in an intermediary Escherichia coli vector, which is rapidly converted via vector-backbone exchange (VBEx) into an organism-specific plasmid ready for high-efficiency transformation. We demonstrated VBEx proof of principle for Lactococcus lactis, but the method can be adapted to all organisms for which plasmids are available.     

Plasmid vector for cloning in Streptococcus pneumoniae and strategies for enrichment for recombinant plasmids

A new plasmid, pLS101, was constructed for use as a vector for cloning in Streptococcus pneumoniae. This plasmid carries two selectable genes, tet and malM, each of which contains two or more restriction sites for cloning. Insertional inactivation of the malM gene allowed direct selection of TcRMal- clones containing recombinant plasmids. Other means of enriching a recipient population for cells containing recombinant plasmids were examined. The effect of removing vector terminal phosphate in attempts to clone heterogeneous DNA fragments, such as those from chromosomal DNA, was to abolish recombinant plasmid establishment altogether, presumably because donor DNA processing during entry into the cell prevented establishment of the hemiligated molecule. However, with homogeneous DNA fragments, such as those from plasmid or viral DNA, vector phosphate removal allowed enrichment for recombinant plasmids. In the cloning of heterogeneous DNA that was homologous to the recipient chromosome (i.e. chromosomal DNA from S. pneumoniae), recovery of recombinant plasmids could be enriched tenfold (relative to the regenerated vector) by the process of chromosomal facilitation of plasmid establishment. This involved an additional passage of the mixed plasmids in which interaction with the chromosome of plasmids containing chromosomal DNA inserts (i.e. recombinant plasmids) increased their frequency of establishment relative to the vector plasmid. An overall strategy for cloning in S. pneumoniae, depending on the nature of the fragment to be cloned, is proposed.     

Generating In Vivo Cloning Vectors for Parallel Cloning of Large Gene Clusters by Homologous Recombination

A robust method for the in vivo cloning of large gene clusters was developed based on homologous recombination (HR), requiring only the transformation of PCR products into Escherichia coli cells harboring a receiver plasmid. Positive clones were selected by an acquired antibiotic resistance, which was activated by the recruitment of a short ribosome-binding site plus start codon sequence from the PCR products to the upstream position of a silent antibiotic resistance gene in receiver plasmids. This selection was highly stringent and thus the cloning efficiency of the GFPuv gene (size: 0.7 kb) was comparable to that of the conventional restriction-ligation method, reaching up to 4.3 × 10⁴ positive clones per μg of DNA. When we attempted parallel cloning of GFPuv fusion genes (size: 2.0 kb) and carotenoid biosynthesis pathway clusters (sizes: 4 kb, 6 kb, and 10 kb), the cloning efficiency was similarly high regardless of the DNA size, demonstrating that this would be useful for the cloning of large DNA sequences carrying multiple open reading frames. However, restriction analyses of the obtained plasmids showed that the selected cells may contain significant amounts of receiver plasmids without the inserts. To minimize the amount of empty plasmid in the positive selections, the sacB gene encoding a levansucrase was introduced as a counter selection marker in receiver plasmid as it converts sucrose to a toxic levan in the E. coli cells. Consequently, this method yielded completely homogeneous plasmids containing the inserts via the direct transformation of PCR products into E. coli cells.     

Seamless Insert-Plasmid Assembly at High Efficiency and Low Cost

Seamless cloning methods, such as co-transformation cloning, sequence- and ligation-independent cloning (SLIC) or the Gibson assembly, are essential tools for the precise construction of plasmids. The efficiency of co-transformation cloning is however low and the Gibson assembly reagents are expensive. With the aim to improve the robustness of seamless cloning experiments while keeping costs low, we examined the importance of complementary single-stranded DNA ends for co-transformation cloning and the influence of single-stranded gaps in circular plasmids on SLIC cloning efficiency. Most importantly, our data show that single-stranded gaps in double-stranded plasmids, which occur in typical SLIC protocols, can drastically decrease the efficiency at which the DNA transforms competent E. coli bacteria. Accordingly, filling-in of single-stranded gaps using DNA polymerase resulted in increased transformation efficiency. Ligation of the remaining nicks did not lead to a further increase in transformation efficiency. These findings demonstrate that highly efficient insert-plasmid assembly can be achieved by using only T5 exonuclease and Phusion DNA polymerase, without Taq DNA ligase from the original Gibson protocol, which significantly reduces the cost of the reactions. We successfully used this modified Gibson assembly protocol with two short insert-plasmid overlap regions, each counting only 15 nucleotides.     

Vectors for ligation-independent construction of lacZ gene fusions and cloning of PCR products using a nicking endonuclease

Several ligation-independent cloning methods have been developed that offer advantages for construction of recombinant plasmids at high efficiency while minimizing cloning artifacts. Here we report new plasmid vectors that use the nicking endonuclease Nt.BspQI to generate extended single stranded tails for direct cloning of PCR products. The vectors include pLacCOs1, a ColE1-derivative plasmid imparting resistance to ampicillin, which allows facile construction of lacZ translational fusions and pKanCOs1, a pSC101-derivative cloning vector that imparts resistance to kanamycin, for cloning of PCR amplicons from genomic DNA as well as from ampicillin-based plasmids. We have successfully used these plasmids to directionally clone and characterize bacterial promoters that exhibit temperature regulated expression, as well as for cloning a variety of PCR products. In all cases, constructs with the correct configurations were generated at high efficiency and with a minimal number of manipulations. The cloning vectors can also be easily modified to incorporate additional reporter genes or to express epitope-tagged gene products.